Tango Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Tango Therapeutics is a clinical-stage biotechnology company based in Boston, Massachusetts, focused on discovering novel drug targets and delivering precision cancer medicines. The company uses a discovery platform that combines DNA sequencing and CRISPR-based target discovery to identify cancer targets for therapeutic development. Tango concentrates on three areas of cancer biology - loss of tumor suppressor gene function, multiple oncogenic drivers, and immune evasion - each in patient populations with limited treatment options. Its approach centers on synthetic lethality, aiming to selectively induce cancer cell death while minimizing effects on normal cells. Founded in 2017 with a Series A led by Third Rock Ventures, Tango employs a staff of 51 to 200 people.
1-888-653-2347 
support@leadiq.com 
